Verve Therapeutics, Inc. (VERV)
Largest Insider Buys in Sector
VERV Stock Price History Chart
VERV Stock Performance
About Verve Therapeutics, Inc.
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Verve Therapeutics, Inc.
Over the last 12 months, insiders at Verve Therapeutics, Inc. have bought $18.48M and sold $18,819 worth of Verve Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Verve Therapeutics, Inc. have bought $51.11M and sold $23.8M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Yeshwant Krishna () — $18M. Ashe Andrew D. (See Remarks) — $475,760.
The last purchase of 76,000 shares for transaction amount of $475,760 was made by Ashe Andrew D. (See Remarks) on 2024‑05‑14.
List of Insider Buy and Sell Transactions, Verve Therapeutics, Inc.
| 2024-05-14 | Ashe Andrew D. | See Remarks | 76,000 0.0972% | $6.26 | $475,760 | -15.01% | ||
| 2024-04-02 | Sale | Nickerson Joan | Chief Administrative Officer | 1,514 0.0019% | $8.24 | $12,475 | -27.28% | |
| 2023-12-01 | Yeshwant Krishna | 1.8M 2.4091% | $10.00 | $18M | +1.03% | |||
| 2023-11-29 | Sale | Dorval Allison | Chief Financial Officer | 554 0.0009% | $11.45 | $6,343 | +4.78% | |
| 2022-12-01 | Sale | Bellinger Andrew | CSO & CMO | 865 0.005% | $22.95 | $19,852 | -25.32% | |
| 2022-11-29 | Sale | Dorval Allison | Chief Financial Officer | 554 0.0032% | $22.10 | $12,243 | -21.87% | |
| 2022-11-04 | Sale | Yeshwant Krishna | director | 48,583 0.2725% | $31.14 | $1.51M | -43.27% | |
| 2022-11-04 | Sale | GV 2017 GP, L.L.C. | director | 194,332 1.0902% | $31.14 | $6.05M | -43.27% | |
| 2022-11-03 | Sale | Yeshwant Krishna | director | 49,568 0.2835% | $32.79 | $1.63M | -44.93% | |
| 2022-11-03 | Sale | GV 2017 GP, L.L.C. | director | 71,847 0.4091% | $32.65 | $2.35M | -44.93% | |
| 2022-11-03 | Sale | GV 2017 GP, L.L.C. | director | 99,137 0.567% | $32.79 | $3.25M | -44.93% | |
| 2022-11-02 | Sale | Yeshwant Krishna | director | 28,652 0.1679% | $35.94 | $1.03M | -48.38% | |
| 2022-11-02 | Sale | GV 2017 GP, L.L.C. | director | 38,001 0.2209% | $35.66 | $1.35M | -48.38% | |
| 2022-11-02 | Sale | GV 2017 GP, L.L.C. | director | 48,373 0.2822% | $35.79 | $1.73M | -48.38% | |
| 2022-11-01 | Sale | Yeshwant Krishna | director | 31,963 0.1819% | $36.79 | $1.18M | -50.88% | |
| 2022-11-01 | Sale | GV 2017 GP, L.L.C. | director | 63,926 0.3638% | $36.79 | $2.35M | -50.88% | |
| 2022-10-31 | Sale | Yeshwant Krishna | director | 53,696 0.3102% | $38.64 | $2.07M | -52.36% | |
| 2022-10-31 | Sale | GV 2017 GP, L.L.C. | director | 107,305 0.6199% | $38.64 | $4.15M | -52.36% | |
| 2022-10-28 | Sale | Bellinger Andrew | CSO & CMO | 10,000 0.0553% | $39.90 | $399,000 | -55.82% | |
| 2022-10-03 | Sale | Kathiresan Sekar | Chief Executive Officer | 50,000 0.2839% | $33.65 | $1.68M |
Insider Historical Profitability
| Yeshwant Krishna | 1800000 2.2916% | $5.02 | 1 | 5 | ||
| Ashe Andrew D. | See Remarks | 342509 0.2173% | $5.02 | 2 | 0 | <0.0001% |
| Nickerson Joan | Chief Administrative Officer | 8659 0.011% | $5.02 | 0 | 1 | |
| Dorval Allison | Chief Financial Officer | 4060 0.0052% | $5.02 | 0 | 2 | |
| Casdin Partners Master Fund, L.P. | 10 percent owner | 2417596 3.0778% | $5.02 | 1 | 0 | <0.0001% |
| Redmile Group, LLC | 10 percent owner | 1936530 2.4654% | $5.02 | 1 | 0 | <0.0001% |
| Cormorant Asset Management, LP | 984224 1.253% | $5.02 | 1 | 0 | <0.0001% | |
| Rock Springs Capital Management LP | 10 percent owner | 926298 1.1793% | $5.02 | 1 | 0 | <0.0001% |
| Novo Holdings A/S | 10 percent owner | 793265 1.0099% | $5.02 | 1 | 0 | <0.0001% |
| FMR LLC | 570729 0.7266% | $5.02 | 0 | 9 | ||
| Logos Global Management LP | 10 percent owner | 370000 0.471% | $5.02 | 1 | 0 | <0.0001% |
| Kathiresan Sekar | Chief Executive Officer | 317839 0.4046% | $5.02 | 1 | 8 | <0.0001% |
| ADELMAN BURT A | 18700 0.0238% | $5.02 | 3 | 0 | +20.97% | |
| Bellinger Andrew | CSO & CMO | 6629 0.0084% | $5.02 | 1 | 5 | <0.0001% |
| Beaudoin Margaret | Vice President, Finance | 1000 0.0013% | $5.02 | 1 | 0 | <0.0001% |
| GV 2017 GP, L.L.C. | director | 0 0% | $5.02 | 0 | 7 |
Institutional Investor Ownership
| Alphabet | $164M | 14.71 | 12.35M | 0% | +$0 | 6.54 | |
| The Vanguard Group | $84.08M | 7.54 | 6.33M | +15.71% | +$11.41M | <0.01 | |
| ARK Investment Management LLC | $80.22M | 7.19 | 6.04M | -14.02% | -$13.08M | 0.56 | |
| BlackRock | $71.36M | 6.4 | 5.37M | +21.14% | +$12.45M | <0.01 | |
| State Street | $67.69M | 6.07 | 5.1M | +31.83% | +$16.34M | <0.01 | |
| T Rowe Price Investment Management Inc | $60.77M | 5.45 | 4.58M | +44.17% | +$18.62M | 0.04 | |
| Federated Hermes | $47.23M | 4.24 | 3.56M | -10.65% | -$5.63M | 0.11 | |
| Fidelity Investments | $44.85M | 4.02 | 3.38M | -1.95% | -$891,035.01 | <0.01 | |
| Casdin Capital | $40.62M | 3.64 | 3.06M | +1.66% | +$663,999.99 | 3.02 | |
| Nikko Asset Management Americas Inc | $34.35M | 3.09 | 2.59M | +8.12% | +$2.58M | 0.33 | |
| Sumitomo Mitsui Trust Holdings | $34.42M | 3.09 | 2.59M | +8.12% | +$2.58M | 0.02 | |
| Arch Venture Management Llc | $26.68M | 2.39 | 2.01M | 0% | +$0 | 37.9 | |
| Novo Holdings A/S | $26.56M | 2.38 | 2M | 0% | +$0 | 1.86 | |
| Baker Bros Advisors LP | $22.46M | 2.02 | 1.69M | 0% | +$0 | 0.28 | |
| Redmile Group | $21.31M | 1.91 | 1.6M | -6.64% | -$1.52M | 0.79 | |
| JPMorgan Chase | $19.83M | 1.78 | 1.49M | -27.46% | -$7.51M | <0.01 | |
| Geode Capital Management | $19.25M | 1.73 | 1.45M | +28.25% | +$4.24M | <0.01 | |
| Ecor1 Capital Llc | $16.6M | 1.49 | 1.25M | 0% | +$0 | 0.42 | |
| Citadel Advisors LLC | $15.63M | 1.4 | 1.18M | +161.68% | +$9.66M | 0.01 | |
| Morgan Stanley | $11.76M | 1.06 | 885,566 | +155.28% | +$7.15M | <0.01 | |
| Nuveen | $11.62M | 1.04 | 875,219 | +90.99% | +$5.54M | <0.01 | |
| Goldman Sachs | $11.03M | 0.99 | 830,870 | +75.43% | +$4.74M | <0.01 | |
| Bvf Inc Il | $8.63M | 0.77 | 650,000 | 0% | +$0 | 0.06 | |
| Bioimpact Capital Llc | $8.47M | 0.76 | 638,163 | 0% | +$0 | 1.37 | |
| Millennium Management LLC | $8.16M | 0.73 | 614,430 | New | +$8.16M | 0.01 | |
| Northern Trust | $7.71M | 0.69 | 580,782 | +17.74% | +$1.16M | <0.01 | |
| Palo Alto Investors Lp | $7.65M | 0.69 | 575,817 | 0% | +$0 | 0.86 | |
| Woodline Partners LP | $6.92M | 0.62 | 521,112 | +<0.01% | +$305.44 | 0.07 | |
| Dimensional Fund Advisors | $6.53M | 0.59 | 491,391 | +115.32% | +$3.5M | <0.01 | |
| Charles Schwab | $6.47M | 0.58 | 487,007 | +31.74% | +$1.56M | <0.01 | |
| Rafferty Asset Management Llc | $6.29M | 0.56 | 473,583 | +34.58% | +$1.62M | 0.02 | |
| Citigroup | $4.99M | 0.45 | 376,059 | +161.67% | +$3.09M | <0.01 | |
| Bank of America | $4.96M | 0.44 | 373,224 | +56.9% | +$1.8M | <0.0001 | |
| Cormorant Asset Management Lp | $4.65M | 0.42 | 350,000 | 0% | +$0 | 0.22 | |
| Candriam S C A | $4.12M | 0.37 | 310,000 | 0% | +$0 | 0.03 | |
| D. E. Shaw & Co. | $4.12M | 0.37 | 310,205 | +39.7% | +$1.17M | 0.01 | |
| UBS | $3.88M | 0.35 | 291,984 | +43.59% | +$1.18M | <0.01 | |
| Wellington Management Company | $3.36M | 0.3 | 253,034 | +60.92% | +$1.27M | <0.01 | |
| Two Sigma | $3.26M | 0.29 | 245,582 | +220.97% | +$2.25M | 0.01 | |
| BNY Mellon | $2.99M | 0.27 | 224,951 | +12.38% | +$329,024.59 | <0.01 | |
| Renaissance Technologies | $2.65M | 0.24 | 199,327 | +21.12% | +$461,601.89 | <0.01 | |
| PDT Partners | $2.53M | 0.23 | 190,608 | +169.87% | +$1.59M | 0.19 | |
| Mirae Asset Global Investments Co Ltd | $2.45M | 0.21 | 171,795 | +52.35% | +$841,431.14 | <0.01 | |
| Trexquant Investment LP | $2.16M | 0.19 | 162,763 | New | +$2.16M | 0.03 | |
| Cubist Systematic Strategies | $1.52M | 0.14 | 114,526 | -20.43% | -$390,524.89 | 0.01 | |
| Stifel | $1.51M | 0.14 | 113,955 | +34.52% | +$388,387.03 | <0.01 | |
| Vestmark Advisory Solutions Inc | $1.41M | 0.13 | 106,093 | -6.38% | -$96,027.68 | 0.08 | |
| Swiss National Bank | $1.37M | 0.12 | 103,200 | -4.88% | -$70,384.00 | <0.01 | |
| Ameriprise Financial | $1.33M | 0.12 | 99,960 | -3.58% | -$49,308.65 | <0.0001 | |
| RhumbLine Advisers | $1.33M | 0.12 | 100,247 | +23.46% | +$252,941.47 | <0.01 |